Skip to content

Clinical trials

Terminated Alzheimer Disease trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Status: Terminated Country / region: France Clear all

73 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20051
20061
20073
20085
20094
20103
20111
20125
20137
20143
20154
201610
20176
20187
20193
20203
20213
20221
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated73

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche6
Biogen5
Centre Hospitalier Universitaire de Saint Etienne5
Pfizer5
Centre Hospitalier Universitaire de Nice4
Nantes University Hospital4
AstraZeneca3
Eli Lilly and Company3
Janssen Research & Development, LLC3
University Hospital, Montpellier3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease73
Dementia15
Cognitive Dysfunction9
Brain Diseases8
Mental Disorders7
Neurodegenerative Diseases7
Nervous System Diseases6
Central Nervous System Diseases5
Parkinson Disease5
Tauopathies5

Trials

Showing 1 to 25 of 73. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.